SARS-CoV-2 infection among patients with haematological disorders: Severity and one-month outcome in 66 Danish patients in a nationwide cohort study.

Bookmark this %label%

Patients with haematological disorders may be particularly vulnerable to respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, however this is unknown.We conducted a prospective, nationwide study including 66 patients in follow-up at […]

» Read more

Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.

Bookmark this %label%

Several small studies on patients with COVID-19 and haematological malignancies are available showing a high mortality in this population. The Italian Hematology Alliance on COVID-19 aimed to collect data from […]

» Read more

Characteristics of peripheral blood differential counts in hospitalized patients with COVID-19.

Bookmark this %label%

A lot remains unknown about the features and laboratory findings that may predict worse outcomes in patients with Coronavirus disease 2019 (COVID-19). The aim of this study was to evaluate […]

» Read more

Managing the front-line treatment for diffuse large B-cell lymphoma and high-grade B-cell lymphoma during the COVID-19 outbreak.

Bookmark this %label%

The COVID-19 pandemic has dramatically challenged care for cancer patients, especially those with active treatment that represent a vulnerable population for SARS-CoV-2 infection. Aggressive lymphoid neoplasms, such as diffuse large […]

» Read more

Outcome of COVID-19 in multiple myeloma patients in relation to treatment.

Bookmark this %label%

COVID-19 has emerged as a global pandemic. Cancer patients have been reported to be at higher risk for adverse outcome of COVID-19. Studies are ongoing to decipher the risk factors […]

» Read more

[COVID-19 from the Perspective of Haematology and Haemostaseology].

Bookmark this %label%

Infection with SARS-COV-2 leads to a number of pathologies in the hematopoetic system that have significant impact on clinical symptoms and mortality. There are 3 stages of infection: (1) early […]

» Read more

Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.

Bookmark this %label%

The impact of coronavirus disease 2019 (COVID-19) in haematological patients (HP) has not been reported to date.We analyzed 39 patients with SARS-CoV-2 infection and haematological malignancies. Clinical characteristics and outcomes […]

» Read more

Transfusion demand in COVID-19 patients from the Korean population: a nationwide study in South Korea.

Bookmark this %label%

As patients infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) often present coagulopathy depending on disease severity, appropriate prevention and treatment for hemodynamics control are most essential for Coronavirus […]

» Read more

Clinical outcomes and risk factors for severe COVID-19 infection in patients with haematological disorders receiving chemo- or immunotherapy.

Bookmark this %label%

Haematology patients receiving chemo- or immunotherapy are considered to be at greater risk of COVID-19-related morbidity and mortality. We aimed to identify risk factors for COVID-19 severity and assess outcomes […]

» Read more

Single-cell oxygen saturation imaging shows that gas exchange by red blood cells is not impaired in COVID-19 patients.

Bookmark this %label%

SARS-CoV-2 coronavirus infection is characterised by a marked inflammatory state and viral pneumonitis. A striking clinical feature is severe hypoxaemia, often in the presence of near-normal lung mechanics. Get PDF […]

» Read more

Clinical characteristics, management and outcome of Covid-19-associated immune thrombocytopenia. A French multicenter series.

Bookmark this %label%

The causes of secondary immune thrombocytopenia (ITP), which account for approximately 18 to 20% of all adult ITP cases, include some viral infections (Cines et al, 2009; Moulis et al, […]

» Read more

An integrated electronic health record facilitates a safer and more efficient rural outreach haematology service.

Bookmark this %label%

Rural Australian oncology patients are known to have inferior mortality rates compared to metropolitan patients, possibly related to access to appropriate healthcare services and treatments. Electronic systems improve the safety […]

» Read more

Hematolological Manifestations of COVID-19: From Cytopenia to Coagulopathy.

Bookmark this %label%

s Emerging data from the management of patients with Coronavirus Disease 2019 (COVID-19) suggests multisystemic involvement, including the hemopoietic system. The hematological manifestations of COVID-19 include blood count anomalies notably […]

» Read more

Haematological characteristics and risk factors in the classification and prognosis evaluation of COVID-19: a retrospective cohort study.

Bookmark this %label%

COVID-19 is an ongoing global pandemic. Changes in haematological characteristics in patients with COVID-19 are emerging as important features of the disease. We aimed to explore the haematological characteristics and […]

» Read more

Blood cell counts and lymphocyte subsets of patients admitted during the COVID-19 pandemic: a prospective cohort study.

Bookmark this %label%

Aberrant blood cell counts, most prominently lymphopenia, have been identified as markers of the degree of severity of coronavirus disease 2019 (COVID-19) (Terpos et al, 2020; Yang et al, 2020; […]

» Read more

Varying Presentations and Favourable Outcomes of COVID-19 Infection in Children and Young Adults with Sickle Cell Disease: An Additional Case Series with Comparisons to Published Cases.

Bookmark this %label%

Patients with sickle cell disease (SCD) are theoretically at greater risk for serious illness from COVID 19 due to the underlying pathophysiology of chronic inflammation with an increased risk of […]

» Read more

Remdesivir during induction chemotherapy for newly diagnosed paediatric acute lymphoblastic leukaemia with concomitant SARS-CoV-2 infection.

Bookmark this %label%

The COVID-19 pandemic potentially makes treatment of acute leukaemia more difficult. Most induction chemotherapy regimens for acute leukaemia lead to extended periods of cytopaenia and immunosuppression rendering patients vulnerable to […]

» Read more

Double-bright (CD56bright/CD16bright) NK cell adoptive immunotherapy for SARS-CoV-2.

Bookmark this %label%

SARS-CoV-2, affecting predominantly elderlies, was recognized as a global pandemic in March 11th , 2020; clinical signs and laboratory alterations are similar to previous coronavirus epidemics with lymphocytopenia and neutrophilia […]

» Read more

COVID-19 comorbidities, associated pro-coagulant extracellular vesicles and venous thromboembolisms: a possible link with ethnicity?

Bookmark this %label%

Several comorbidities predict mortality in patients with COVID-19, some of which are more prevalent in Black Asian and Minority Ethnic (BAME) groups. Extracellular vesicles (EVs) released from cells are nano-sized […]

» Read more

Heterogeneity in reporting venous thromboembolic phenotypes in COVID-19: Methodological issues and clinical implications.

Bookmark this %label%

COVID-19 is associated with increased risk of venous thromboembolic events (VTE). However, there is significant heterogeneity in the thromboembolic phenotypes of COVID-19 patients (deep vein thrombosis, pulmonary embolism/thrombosis). The latter […]

» Read more
1 2 3 5